BackAlto Neuroscience Overview
Alto Neuroscience Inc.

Alto Neuroscience Target Price

Analysts' average 12-month price target for Alto Neuroscience is $37.

Get informed when a big investor buys or sells

+ Follow

Share Price

$29.18

Average Target Price

$36.6725.7% upside

3 analysts in the last 4 months

High: $50 | Low: $24

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-27H.C. WainwrightPatrick Trucchio$5071.4% upsideOpen
2026-05-18Robert W. Baird$3623.4% upsideOpen
2026-05-14WedbushLaura Chico$2417.8% downsideOpen
2026-03-16JefferiesAndrew Tsai$3519.9% upsideOpen
2026-02-17BTIGThomas Shrader$284% downsideOpen
2025-10-20Robert W. Baird$1645.2% downsideOpen
2024-10-23Robert W. BairdBrian Skorney$1065.7% downsideOpen
2024-06-20Robert W. BairdBrian Skorney$329.7% upsideOpen

Alto Neuroscience (ANRO) FAQ

Alto Neuroscience's target price stands at $37. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $37 for ANRO implies 25.7% upside versus today's price ($29.18). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Alto Neuroscience's target price evolved across reporting periods, while the comparison chart places ANRO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.